335
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Evaluating the association between all components of the metabolic syndrome and pre-eclampsia

, MD, , MD, , , , , , & show all
Pages 501-509 | Received 29 Oct 2008, Accepted 30 Jan 2009, Published online: 21 Jul 2009

References

  • Chang J, Elam-Evans L D, Berg C J, Herndon J, Flowers L, Seed K A, Syverson C J. Pregnancy-related mortality surveillance – United States, 1991–1999. MMWR 2003; 52: 1–8
  • CDC, Achievements in Public Health, Healthier Mothers and Babies; 1990–1999.
  • Irgens H U, Reisaeter L, Irgens L M, Lie R T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323: 1213–1217
  • Rey E, Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1995; 171: 410–416
  • Sibai B M, Caritis S, Hauth J, Lindheimer M, VanDorsten J P, MacPherson C, Klebanoff M, Landon M, Miodovnik M, Paul R, Meis P, Dombrowski M, Thurnau G, Roberts J, McNellis D. Risks of pre-eclampsia and adverse neonatal outcome among women with pre-gestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000; 182: 364–369
  • Forest J C, Girouard J, Massé J, Moutquin J M, Kharfi A, Ness R B, Roberts J M, Giguère Y. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005; 105: 1373–1380
  • Pouta A, Hartikainen A L, Sovio U, Gissler M, Laitinen J, McCarthy A R, Elliott P, Jarvelin M. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 2004; 43: 825–831
  • Ray J G, Vermeulen M J, Schull M J, Redelmeier D A. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005; 366: 1797–1803
  • Funai E F, Friedlander Y, Paltiel O, Tiram E, Xue X, Deutsch L, Harlap S. Long-term mortality after pre-eclampsia. Epidemiology 2005; 16: 206–215
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Panel (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497
  • Grundy S M, Cleeman J I, Daniels S R, Donato K A, Eckel R H, Franklin B A, Gordon D J, Krauss R M, Savage P J, Smith S C, Jr, Spertus J A, Costa F, American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752
  • Grundy S M. Inflammation, hypertension, and the metabolic syndrome. JAMA 2003; 290: 3000–3002
  • Bonora E. The metabolic syndrome and cardiovascular disease. Ann Med 2006; 38: 64–80
  • Ridker P M, Buring J E, Cook J E, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107: 391–397
  • Ridker P M. C-reactive protein, inflammation, and cardiovascular disease: clinical update. Tex Heart Inst J 2005; 32: 384–386
  • Mazar R, Srinivas S K, Sammel M D, Andrela C M, Elovitz M A. Metabolic score as a novel approach to assessing pre-eclampsia risk. Am J Obstet Gynecol 2007; 197: el–e5, 411
  • ACOG Committee on Practice Bulletins – Obstetrics. ACOG practice bulletin. Diagnosis and management of pre-eclampsia and ecclampsia. Number 33, January. Obstet Gynecol 2002; 99: 159–167
  • Reilly M P, Wolfe M L, Localio A R, Rader D J. C-reactive protein and coronary artery calcification: the Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 2003; 23: 1851–1856
  • Reilly M P, Wolfe M L, Rhodes T, Girman C, Mehta N, Rader D J. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 2004; 110: 803–809
  • Reilly M P, Foulkes A S, Wolfe M L, Rader D J. Higher order lipase gene association with plasma triglycerides. J Lipid Res 2005; 46: 1914–1922
  • McLaughlin M T, Abbasi F, Kim H S, Lamendola C, Schaff P, Reaven G. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 2001; 50: 795–800
  • Center for Disease control and Prevention. State specific Prevalence of obesity among adults. United States, 2005. MMWR 2005; 55: 985–988
  • Ray J G, Diamond P, Singh G, Bell C M. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 2006; 113: 379–386
  • Enquobahrie D A, Williams M A, Butler C L, Frederick I O, Miller R S, Luthy D A. Maternal plasma lipid concentrations in early pregnancy and risk of pre-eclampsia. Am J Hypertens 2004; 17: 574–581
  • Belo L, Caslake M, Santos-Silva A, Castro E M, Pereira-Leite L, Quintanilha A, Rebelo I. LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study. Atherosclerosis 2004; 177: 391–399
  • Kaaja R J, Greer I A. Manifestations of chronic disease during pregnancy. JAMA 2005; 294: 2751–2757
  • Roberts J M. Pre-eclampsia: what we know and what we do not know. Semin Perinatol 2000; 24: 24–28
  • Hubel C A, McLaughlin M K, Evans R W, Hauth B A, Sims C J, Roberts J M. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in pre-eclampsia, are positively correlated and decrease within 48 hours postpartum. Am J Obstet Gynecol 1996; 174: 975–982
  • Amowitz L L, Ridker P M, Rifai N, Koughrey C M, Komaroff A L. High prevalence of metabolic syndrome among young women with nonfatal myocardial infarction. J Womens Health 2004; 13: 165–175
  • Baksu B, Baksu A, Davas I, Akyol A, Gulbaba G. Lipoprotein(a) levels in women with pre-eclampsia and in normotensive pregnant women. J Obstet Gynaecol Res 2005; 31: 277–282
  • Kaaja R K, Greer I A. Manifestations of chronic disease during pregnancy. JAMA 2005; 294: 2751–2757
  • Wolf M, Hubel C A, Lam C, Sampson M, Ecker J L, Ness R B, Rajakumar A, Daftary A, Shakir A S, Seely E W, et al. Pre-eclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metabol 2004; 89: 6239–6243
  • Brown D W, Dueker N, Jamieson D J, Cole J W, Wozniak M A, Stern B J, Giles W H, Kittner S J. Pre-eclampsia and the risk of ischemic stroke among young women: results from the Stroke prevention in young women study. Stroke 2006; 37: 1055–1059
  • Sattar N, Greer I A. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 2002; 325: 157–160
  • Rodie V A, Freeman D J, Sattar N, Greer I A. Pre-eclampsia and cardiovascular risk: metabolic syndrome of pregnancy?. Atherosclerosis 2004; 175: 189–202
  • Ness R B, Hubel C A. Risk for conronary artery disease and morbid pre-eclampsia; A commentary. Ann Epidemiology 2005; 15: 726–733

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.